Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use...

by Ella Willenbacher, Roman Weger, Ursula Rochau, Uwe Siebert, Wolfgang Willenbacher, Austrian Myeloma Registry (AMR)
Published 2016-01-01

Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests Oncot...

by Beate Jahn, Ursula Rochau, Christina Kurzthaler, Michael Hubalek, Rebecca Miksad, Gaby Sroczynski, Mike Paulden, Marvin Bundo, David Stenehjem, Diana Brixner, Murray Krahn, Uwe Siebert
Published 2017-10-01

The economic impact of prevention, monitoring and treatment strategies for iodine deficiency disorders in Germany

by Monika Schaffner, Ursula Rochau, Nikolai Mühlberger, Annette Conrads-Frank, Vjollca Qerimi Rushaj, Gaby Sroczynski, Eftychia Koukkou, Betina Heinsbaek Thuesen, Henry Völzke, Wilhelm Oberaigner, Uwe Siebert
Published 2021-01-01

Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria

by Beate Jahn, Gaby Sroczynski, Marvin Bundo, Nikolai Mühlberger, Sibylle Puntscher, Jovan Todorovic, Ursula Rochau, Willi Oberaigner, Hendrik Koffijberg, Timo Fischer, Irmgard Schiller-Fruehwirth, Dietmar Öfner, Friedrich Renner, Michael Jonas, Monika Hackl, Monika Ferlitsch, Uwe Siebert, on behalf of the Austrian Colorectal Cancer Screening Model Group
Published 2019-12-01